Metabolism of [14C]2-aminobiphenyl in vivo by different species.
M Kajbaf, J W Gorrod
Index: Eur. J. Drug Metab. Pharmacokinet. 12(4) , 285-90, (1987)
Full Text: HTML
Abstract
[14C] 2-Aminobiphenyl is predominantly metabolised in vivo to 3- and 5-hydroxy conjugated derivatives in all species. In some species, 2-aminobiphenyl is also excreted to a small extent as N-conjugated derivatives. Renal excretion accounts for about 30-40% of the administered dose during the first 24 hours. The 5-O-sulphate and 5-O-glucuronide of 2-amino-5-hydroxybiphenyl have been found as major metabolites with all species; 2-amino-3-hydroxybiphenyl-O-sulphate is also a significant metabolite. There were metabolic differences observed between species in this study. HPLC and TLC analytical techniques were used for separation and detection of [14C] 2-aminobiphenyl and its metabolites. Formation of different isomeric metabolites may be explained by electronic Hückel molecular orbital calculations and stereochemical factors.
Related Compounds
Related Articles:
Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.
1988-12-01
[Proc. Natl. Acad. Sci. U. S. A. 85(24) , 9788-91, (1988)]
Haemoglobin adducts of aromatic amines in people exposed to cigarette smoke.
1988-01-01
[IARC Sci. Publ. (89) , 133-6, (1988)]
Elevated blood levels of carcinogens in passive smokers.
1989-10-01
[Am. J. Public Health 79(10) , 1381-4, (1989)]
Nonsmoking-related arylamine exposure and bladder cancer risk.
2003-06-01
[Cancer Epidemiol. Biomarkers Prev. 12(6) , 503-7, (2003)]
Haemoglobin adducts formed by aromatic amines in smokers: sources of inter-individual variability.
1990-04-01
[Br. J. Cancer 61(4) , 534-7, (1990)]